Cargando…
Spinal Central Effects of Peripherally Applied Botulinum Neurotoxin A in Comparison between Its Subtypes A1 and A2
Because of its unique ability to exert long-lasting synaptic transmission blockade, botulinum neurotoxin A (BoNT/A) is used to treat a wide variety of disorders involving peripheral nerve terminal hyperexcitability. However, it has been a matter of debate whether this toxin has central or peripheral...
Autores principales: | Koizumi, Hidetaka, Goto, Satoshi, Okita, Shinya, Morigaki, Ryoma, Akaike, Norio, Torii, Yasushi, Harakawa, Tetsuhiro, Ginnaga, Akihiro, Kaji, Ryuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066301/ https://www.ncbi.nlm.nih.gov/pubmed/25002857 http://dx.doi.org/10.3389/fneur.2014.00098 |
Ejemplares similares
-
Response of striosomal opioid signaling to dopamine depletion in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: a potential compensatory role
por: Koizumi, Hidetaka, et al.
Publicado: (2013) -
Development of a highly sensitive immunohistochemical method to detect neurochemical molecules in formalin-fixed and paraffin-embedded tissues from autopsied human brains
por: Goto, Satoshi, et al.
Publicado: (2015) -
Dopamine signaling negatively regulates striatal phosphorylation of Cdk5 at tyrosine 15 in mice
por: Yamamura, Yukio, et al.
Publicado: (2013) -
Dopamine-Induced Changes in Gα(olf) Protein Levels in Striatonigral and Striatopallidal Medium Spiny Neurons Underlie the Genesis of l-DOPA-Induced Dyskinesia in Parkinsonian Mice
por: Morigaki, Ryoma, et al.
Publicado: (2017) -
Clinical Safety and Tolerability of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Botulinum Neurotoxin Subtype A2, in Comparison with Subtype A1 Toxins
por: Takeuchi, Toshiaki, et al.
Publicado: (2021)